Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Microtubule
>>
Phase 2
«
1
2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
praluzatamab ravtansine
(CX-2009) / CytomX, AbbVie
thimerosal
(BTL-TML) / Beech Tree Labs
AB8939
/ AB Science
AGS-16C3F
/ Astellas
AZD0305
/ AstraZeneca
BMS-986148
/ BMS
OC-10X
/ OcuCure Therap
STRO-001
/ Sutro Biopharma
cantuzumab ravtansine
(IMGN242) / AbbVie
crolibulin
(EPC2407) / Immune Pharma
docetaxel-loaded nanopharmaceutical
(CRLX301) / Ellipses Pharma
enapotamab vedotin
(HuMax-AXL-ADC) / Genmab
epofolate
(BMS-753493) / BMS
izeltabart tapatansine
(IMGC936) / MacroGenics, AbbVie
naratuximab emtansine
(DEBIO 1562) / Debiopharm
pinatuzumab vedotin
(RG7593) / Roche
pregnenolone methyl ether
(MAP4343) / Mapreg
samatatug zovodotin
(XB002) / Exelixis
AMXI-5001
/ AtlasMedx
BIO-106
/ BiOneCure
BT1718
/ Bicycle Therap
CX-2029
/ CytomX
DEP cabazitaxel
(CTX-SPL9111) / Starpharma
LCB84
/ J&J
Lipax
(proliposomal intravesical paclitaxel) / TesoRx
MEDI4276
/ AstraZeneca
MRG004A
/ Lepu Med
Noscovid
(novel noscapine) / Qazvin University of Medical Sciences
OBI-999
/ OBI Pharma
PRO1107
/ Genmab
REGN5093-M114
/ Regeneron
cabazitaxel-loaded mixed polymeric micelle
(MPB-1734) / MegaPro Biomedical
liposomal vinorelbine
(TLC178) / Taiwan Liposome Company
lonigutamab ugodotin
(W0101) / Pierre Fabre, Roche
nendratareotide uzatansine
(PEN-221) / Tarveda Therap
«
1
2
